Vivos Therapeutics Stock Forecast - Triple Exponential Smoothing

VVOS Stock  USD 3.40  0.12  3.41%   
The Triple Exponential Smoothing forecasted value of Vivos Therapeutics on the next trading day is expected to be 3.45 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.52. Vivos Stock Forecast is based on your current time horizon.
  
At this time, Vivos Therapeutics' Payables Turnover is comparatively stable compared to the past year. Receivables Turnover is likely to gain to 71.74 in 2024, whereas Inventory Turnover is likely to drop 8.30 in 2024. . Common Stock Shares Outstanding is likely to drop to about 899.6 K in 2024. Net Loss is likely to drop to about (19.2 M) in 2024.
Triple exponential smoothing for Vivos Therapeutics - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Vivos Therapeutics prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Vivos Therapeutics price movement. However, neither of these exponential smoothing models address any seasonality of Vivos Therapeutics.

Vivos Therapeutics Triple Exponential Smoothing Price Forecast For the 29th of November

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Vivos Therapeutics on the next trading day is expected to be 3.45 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.06, and the sum of the absolute errors of 9.52.
Please note that although there have been many attempts to predict Vivos Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Vivos Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Vivos Therapeutics Stock Forecast Pattern

Backtest Vivos TherapeuticsVivos Therapeutics Price PredictionBuy or Sell Advice 

Vivos Therapeutics Forecasted Value

In the context of forecasting Vivos Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Vivos Therapeutics' downside and upside margins for the forecasting period are 0.03 and 11.64, respectively. We have considered Vivos Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.40
3.45
Expected Value
11.64
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Vivos Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Vivos Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0268
MADMean absolute deviation0.1587
MAPEMean absolute percentage error0.0536
SAESum of the absolute errors9.522
As with simple exponential smoothing, in triple exponential smoothing models past Vivos Therapeutics observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Vivos Therapeutics observations.

Predictive Modules for Vivos Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vivos Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.183.5211.69
Details
Intrinsic
Valuation
LowRealHigh
0.122.3010.47
Details
2 Analysts
Consensus
LowTargetHigh
1.641.802.00
Details

Other Forecasting Options for Vivos Therapeutics

For every potential investor in Vivos, whether a beginner or expert, Vivos Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vivos Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vivos. Basic forecasting techniques help filter out the noise by identifying Vivos Therapeutics' price trends.

Vivos Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vivos Therapeutics stock to make a market-neutral strategy. Peer analysis of Vivos Therapeutics could also be used in its relative valuation, which is a method of valuing Vivos Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Vivos Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vivos Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vivos Therapeutics' current price.

Vivos Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Vivos Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vivos Therapeutics shares will generate the highest return on investment. By undertsting and applying Vivos Therapeutics stock market strength indicators, traders can identify Vivos Therapeutics entry and exit signals to maximize returns.

Vivos Therapeutics Risk Indicators

The analysis of Vivos Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vivos Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vivos stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.